Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
allogeneic cell therapy
Pharma
Atara hit with cell therapy clinical hold after FDA inspection
After receiving a complete response letter last week, the other shoe has dropped for Atara Biotherapeutics and its pipeline of T-cell immunotherapies.
Fraiser Kansteiner
Jan 21, 2025 9:59am
After two rejections, FDA approves Mesoblast's cell therapy
Dec 19, 2024 11:24am
Aspen Neuroscience levels up in-house cell therapy production
Oct 2, 2024 8:15am
To boost production of T1D candidates, Vertex jumps to TreeFrog
Apr 24, 2024 7:25am
CellTrans gets FDA nod for cell therapy for Type 1 diabetes
Jun 29, 2023 10:27am
